RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Description
RMI Partners is VC firm focused on breakthrough developments of pharmaceutical products and technologies based in the U.S. and Russia.
Investor Profile
RMI Partners has made 29 investments, with 0 in the past 12 months and 45% as lead.
Stage Focus
- Series B (28%)
- Series C (21%)
- Series D (14%)
- Series E (14%)
- Convertible Note (7%)
- Series Unknown (7%)
- Debt Financing (3%)
- Post Ipo Equity (3%)
- Series A (3%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Medical
- Medical Device
- Therapeutics
- Health Diagnostics
- Biopharma
- Oncology
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
